Insmed Incorporated (INSM)
After hours:
| Previous close | 71.04 |
| Open | 71.29 |
| Bid | 71.77 x 300 |
| Ask | 71.93 x 100 |
| Day's range | 71.06 - 72.88 |
| 52-week range | 21.92 - 80.53 |
| Volume | |
| Avg. volume | 2,528,798 |
| Market cap | 12.342B |
| Beta (5Y monthly) | 1.11 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -5.41 |
| Earnings date | 24 Oct 2024 - 28 Oct 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 88.53 |
Insider MonkeyInsmed Incorporated (INSM): Hedge Funds Are Recommending This Biotech Stock Now
We recently compiled a list of the 12 Best Biotech Stocks To Invest In According To Hedge Funds. In this article, we are going to take a look at where Insmed Incorporated (NASDAQ:INSM) stands against the other biotech stocks. As we have mentioned in our article, “10 Best Penny Stocks to Buy Under $1,” the size […]
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced the granting of inducement awards to 60 new employees. In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved by Insmed's Compensation Committee and made as a material inducement to each employee's entry into employment with the Company.
Insider MonkeyInsmed (INSM) Rose Due to Positive Trial Results
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here. Small-cap stocks were unable to sustain the positive gains made in the first quarter and finished the second quarter in negative territory. Among the style indexes, […]
